Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS.
- DOI
- 10.1038/s41408-025-01444-0
- Published
- 2025 Dec 31
- Container
- Blood cancer journal
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41408-025-01444-0,
title = {Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS.},
author = {Komrokji RS and Santini V and Zeidan AM and Sekeres MA and Fenaux P and Raza A and Mittelman M and Thépot S and Buckstein R and Germing U and Madanat YF and Díez-Campelo M and Valcárcel D and Jonášová A and Dougherty S and Shah S and Xia Q and Sun L and Navada S and Feller F and Savona MR and Platzbecker U},
year = {2025},
journal = {Blood cancer journal},
doi = {10.1038/s41408-025-01444-0},
url = {https://doi.org/10.1038/s41408-025-01444-0}
}RIS
TY - JOUR TI - Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS. AU - Komrokji RS AU - Santini V AU - Zeidan AM AU - Sekeres MA AU - Fenaux P AU - Raza A AU - Mittelman M AU - Thépot S AU - Buckstein R AU - Germing U AU - Madanat YF AU - Díez-Campelo M AU - Valcárcel D AU - Jonášová A AU - Dougherty S AU - Shah S AU - Xia Q AU - Sun L AU - Navada S AU - Feller F AU - Savona MR AU - Platzbecker U PY - 2025 JO - Blood cancer journal DO - 10.1038/s41408-025-01444-0 UR - https://doi.org/10.1038/s41408-025-01444-0 ER -
APA
RS, K., V, S., AM, Z., MA, S., P, F., A, R., M, M., S, T., R, B., U, G., YF, M., M, D., D, V., A, J., S, D., S, S., Q, X., L, S., S, N., F, F., MR, S., & U, P. (2025). Effect of prior therapy on the clinical activity of imetelstat in patients with transfusion-dependent, ESA-relapsed or -refractory/-ineligible LR-MDS.. Blood cancer journal. https://doi.org/10.1038/s41408-025-01444-0
Source records
- pubmed · retrieved 2026-09-27T08:37:19.585Z